BIOGEN HEMOPHILIA INC has a total of 36 patent applications. Its first patent ever was published in 2004. It filed its patents most often in EPO (European Patent Office), Hungary and Hong Kong. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are BIOGEN IDEC HEMOPHILIA INC, BIOVERATIV THERAPEUTICS INC and INTEGRATED BIOTHERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | Hungary | 7 | |
#3 | Hong Kong | 4 | |
#4 | Slovenia | 4 | |
#5 | Singapore | 3 | |
#6 | United States | 3 | |
#7 | Mexico | 2 | |
#8 | Netherlands | 2 | |
#9 | Australia | 1 | |
#10 | EAPO (Eurasian Patent Organization) | 1 | |
#11 | New Zealand | 1 | |
#12 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Environmental technology | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Enzymes | |
#6 | Climate change adaptation technologies | |
#7 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Peters Robert T | 22 |
#2 | Bitonti Alan J | 16 |
#3 | Rivera Daniel S | 13 |
#4 | Mezo Adam R | 12 |
#5 | Stattel James M | 9 |
#6 | Jiang Haiyan | 9 |
#7 | Pierce Glenn | 9 |
#8 | Low Susan C | 9 |
#9 | Peters Robert | 7 |
#10 | Luk Alvin | 6 |
Publication | Filing date | Title |
---|---|---|
AU2015200004A1 | Antibodies against fcrn and use thereof | |
EP2298347A1 | Clotting factor chimeric proteins for treatment of a hemostatic disorder |